Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 20/20 | 0.63 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.63 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.63 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.61 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23915866 | 0.91 | S1PR1 (0.59) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22074485 | 0.89 | S1PR1 (0.61) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22077850 | 0.87 | S1PR1 (0.59) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL23915869 | 0.82 | S1PR1 (0.57) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22041461 | 0.80 | S1PR1 (0.68) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL29962447 | 0.80 | S1PR1 (0.68) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22074026 | 0.80 | S1PR1 (0.57) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22084344 | 0.80 | S1PR1 (0.52) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL22074487 | 0.79 | S1PR1 (0.56) | S1PR1S1PR4S1PR5ADORA3S1PR2 | |
| SCHEMBL25713118 | 0.79 | S1PR1 (0.58) | S1PR1S1PR4S1PR5ADORA3S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023125397-A1 | PREPARATION METHOD FOR AROMATIC RING DERIVATIVE FOR IMMUNE REGULATION | 上海济煜医药科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20220017513-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-3892616-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) | 2021-10-13 | — | — | EP | disclosed |
| WO-2020114475-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | 上海济煜医药科技有限公司 | 2020-06-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017513-A1 | AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE | S1PR1, S1PR2, S1PR3 | S1PR1 1/4885S1PR4 4/4885S1PR5 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.